Biohit Oyj Stock Exchange Release March 24, 2014 at 2:45 pm local time (EET)
Biohit Oyj’s Annual Report 2013 is published today as PDF document. The annual report contains a review of information published in 2013.
Report is available in English and Finnish at Biohit company website www.biohithealthcare.com/investors. Printed publication of Annual Report 2013 will be distributed to shareholders in Annual General Meeting.
Attachment: Biohit Oyj Annual Report 2013
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
